Field flow fractionation for assessing neonatal Fc receptor and Fcγ receptor binding to monoclonal antibodies in solution

Analytical Biochemistry

Volumn 414, Issue 1, 2011, Pages 88-98

  Pollastrini, Joey ^a   Dillon, Thomas M ^a   Bondarenko, Pavel ^a   Chou, Robert Y T ^a  

^a AMGEN INC   (United States)

Author keywords

FcRn; Fc receptor; Field flow fraction; Human serum albumin; Monoclonal antibodies; Protein protein interactions; Receptor binding

Indexed keywords

CHEMICAL MODIFICATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOLAR RATIO; MONOCLONAL ANTIBODIES; STOICHIOMETRY; SURFACE PLASMON RESONANCE;

FCRN; FIELD FLOW; HUMAN SERUM ALBUMINS; PROTEIN-PROTEIN INTERACTIONS; RECEPTOR BINDING;

SIZE EXCLUSION CHROMATOGRAPHY;

FC RECEPTOR; HUMAN SERUM ALBUMIN; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY;

ANIMAL CELL; ARTICLE; CHEMICAL MODIFICATION; COMPLEX FORMATION; FIELD FLOW FRACTIONATION; GEL PERMEATION CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; STOICHIOMETRY; SURFACE PROPERTY;

EID: 79955690983     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2011.03.001     Document Type: Article

References (47)

1. R. Jefferis, Glycosylation as a strategy to improve antibody-based therapeutics, Nat. Rev. Drug Discov. 8 (2009) 226-234.
2. A.L. Nelson, E. Dhimolea, J.M. Reichert, Development trends for human monoclonal antibody therapeutics, Nat. Rev. Drug Discov. 9 (2010) 767-774.
3. J.G. Salfeld, Isotype selection in antibody engineering, Nat. Biotechnol. 25 (2007) 1369-1372.
4. J.M. Woof, D.R. Burton, Human antibody-Fc receptor interactions illuminated by crystal structures, Nat. Rev. Immunol. 4 (2004) 89-99. (Pubitemid 38209203)
5. R. Nezlin, V. Ghetie, W.A. Frederick, Interactions of immunoglobulins outside the antigen-combining site, Adv. Immunol. 82 (2004) 155-215.
6. M. Raghavan, P.J. Bjorkman, Fc receptors and their interactions with immunoglobulins, Annu. Rev. Cell Dev. Biol. 12 (1996) 181-220. (Pubitemid 26422713)
7. F. Nimmerjahn, J.V. Ravetch, Fcγ receptors as regulators of immune responses, Nat. Rev. Immunol. 8 (2008) 34-47.
8. C.L. Anderson, C. Chaudhury, J. Kim, C.L. Bronson, M.A. Wani, S. Mohanty, FcRn transports albumin: relevance to immunology and medicine, Trends Immunol. 27 (2006) 343-348. (Pubitemid 43963476)
9. W.I. Lencer, R.S. Blumberg, A passionate kiss, then run: exocytosis and recycling of IgG by FcRn, Trends Cell Biol. 15 (2005) 5-9.
10. K. Baker, S-W. Qiao, T. Kuo, K. Kobayashi, M. Yoshida, W. Lencer, R. Blumberg, Immune and non-immune functions of the (not so) neonatal Fc receptor, FcRn, Semin. Immunopathol. 31 (2009) 223-236.
11. D.C. Roopenian, S. Akilesh, FcRn: The neonatal Fc receptor comes of age, Nat. Rev. Immunol. 7 (2007) 715-725. (Pubitemid 47327396)
12. D.E. Vaughn, P.J. Bjorkman, High-affinity binding of the neonatal Fc receptor to its IgG ligand requires receptor immobilization, Biochemistry 36 (1997) 9374-9380. (Pubitemid 27346975)
13. C. Chaudhury, C.L. Brooks, D.C. Carter, J.M. Robinson, C.L. Anderson, Albumin binding to FcRn: Distinct from the FcRn-IgG interaction, Biochemistry 45 (2006) 4983-4990.
14. W.P. Burmeister, A.H. Huber, P.J. Bjorkman, Crystal structure of the complex of rat neonatal Fc receptor with Fc, Nature 372 (1994) 379-383. (Pubitemid 24363442)
15. S. Popov, J.G. Hubbard, J-K. Kim, B. Ober, V. Ghetie, E.S. Ward, The stoichiometry and affinity of the interaction of murine Fc fragments with the MHC class I-related receptor, FcRn, Mol. Immunol. 33 (1996) 521-530. (Pubitemid 26228389)
16. W.L. Martin, P.J. Bjorkman, Characterization of the 2:1 complex between the class I MHC-related Fc receptor and its Fc ligand in solution, Biochemistry 38 (1999) 12639-12647.
17. L.M. Sanchez, D.M. Penny, P.J. Bjorkman, Stoichiometry of the interaction between the major histocompatibility complex-related Fc receptor and its Fc ligand, Biochemistry 38 (1999) 9471-9476.
18. A.P. West, P.J. Bjorkman, Crystal structure and immunoglobulin G binding properties of the human major histocompatibility complex-related Fc receptor, Biochemistry 39 (2000) 9698-9708. (Pubitemid 30626819)
19. P. Schuck, C.G. Radu, E.S. Ward, Sedimentation equilibrium analysis of recombinant mouse FcRn with murine IgG1, Mol. Immunol. 36 (1999) 1117-1125.
20. S. Cao, J. Pollastrini, Y. Jiang, Separation and characterization of protein aggregates and particles by field flow fractionation, Curr. Pharm. Biotechnol. 10 (2009) 382-390.
21. J.C. Giddings, Field-flow fractionation: analysis of macromolecular, colloidal, and particulate materials, Science 260 (1993) 123-125.
22. P. Reschiglian, A. Zattoni, B. Roda, E. Michelini, A. Roda, Field-flow fractionation and biotechnology, Trends Biotechnol. 23 (2005) 475-483. (Pubitemid 41188247)
23. 2 antibody highlights the role avidity plays in antibody activity, Biochemistry 47 (2008) 2518-2530.
24. D. Ren, G.D. Pipes, D. Liu, L.Y. Shih, A.C. Nichols, M.J. Treuheit, D.N. Brems, P.V. Bondarenko, An improved trypsin digestion method minimizes digestion-induced modifications on proteins, Anal. Biochem. 392 (2009) 12-21.
25. Z. Zhang, Large-scale identification and quantification of covalent modifications in therapeutic proteins, Anal. Chem. 81 (2009) 8354-8364.
26. M.D. Hulett, P.M. Hogarth, Molecular basis of Fc receptor function, Adv. Immunol. 57 (1994) 1-127.
27. J.R. Cann, A.G.A. Rao, D.J. Winzor, Numerical and experimental demonstrations of the need for caution in the use of zonal gel chromatography for characterizing ligand interactions with small acceptors, Arch. Biochem. Biophys. 270 (1989) 173-183. (Pubitemid 19096143)
28. F.J. Stevens, Analysis of protein-protein interaction by simulation of small-zone size exclusion chromatography: stochastic formulation of kinetic rate contributions to observed high-performance liquid chromatography elution characteristics, Biophys. J. 55 (1989) 1155-1167.
29. W. Fraunhofer, G. Winter, The use of asymmetrical flow field-flow fractionation in pharmaceutics and biopharmaceutics, Eur. J. Pharm. Biopharm. 58 (2004) 369-383. (Pubitemid 39037242)
30. K. Kameyama, A.P. Minton, Rapid quantitative characterization of protein interactions by composition gradient static light scattering, Biophys. J. 90 (2006) 2164-2169.
31. A.K. Attri, A.P. Minton, Composition gradient static light scattering: a new technique for rapid detection and quantitative characterization of reversible macromolecular hetero-associations in solution, Anal. Biochem. 346 (2005) 132-138.
32. M. Raghavan, V.R. Bonagura, S.L. Morrison, P.J. Bjorkman, Analysis of the pH dependence of the neonatal Fc receptor/immunoglobulin G interaction using antibody and receptor variants, Biochemistry 34 (1995) 14649-14657.
33. A.H. Huber, R.F. Kelley, L.N. Gastinel, P.J. Bjorkman, Crystallization and stoichiometry of binding of a complex between a rat intestinal Fc receptor and Fc, J. Mol. Biol. 230 (1993) 1077-1083.
34. R. Rodewald, pH-dependent binding of immunoglobulins to intestinal cells of the neonatal rat, J. Cell Biol. 71 (1976) 666-669.
35. R.P. Junghans, C.L. Anderson, The protection receptor for IgG catabolism is the β2-microglobulin-containing neonatal intestinal transport receptor, Proc. Natl. Acad. Sci. USA 93 (1996) 5512-5516.
36. R. Jefferis, J. Lund, Interaction sites on human IgG-Fc for FcγR: current models, Immunol. Lett. 82 (2002) 57-65.
37. J.F.G. Cohen-Solal, L. Cassard, W-H. Fridman, C. Sautès-Fridman, Fcγ receptors, Immunol. Lett. 92 (2004) 199-205.
38. F. Nimmerjahn, J.V. Ravetch, Divergent immunoglobulin G subclass activity through selective Fc receptor binding, Science 310 (2005) 1510-1512. (Pubitemid 41746349)
39. R.L. Shields, J. Lai, R. Keck, L.Y. O'Connell, K. Hong, Y.G. Meng, S.H. Weikert, L.G. Presta, Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human FcγRIII and antibody-dependent cellular toxicity, J. Biol. Chem. 277 (2002) 26733-26740.
40. S. Sibéril, C-A. Dutertre, C. Boix, E. Bonnin, R. Ménez, E. Stura, S. Jorieux, W-H. Fridman, J-L. Teillaud, Molecular aspects of human FcγR interactions with IgG: functional and therapeutic consequences, Immunol. Lett. 106 (2006) 111-118.
41. M. Firan, R. Bawdon, C. Radu, R.J. Ober, D. Eaken, F. Antohe, V. Ghetie, E.S. Ward, The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of γ-globulin in humans, Intl. Immunol. 13 (2001) 993-1002. (Pubitemid 32750502)
42. H. Pan, K. Chen, L. Chu, F. Kinderman, I. Apostol, G. Huang, Methionine oxidation in human IgG2 Fc decreases binding affinities to protein A and FcRn, Protein Sci. 18 (2009) 424-433.
43. B.M. Gurbaxani, S.L. Morrison, Development of new models for the analysis of Fc-FcRn interactions, Mol. Immunol. 43 (2006) 1379-1389.
44. C. Chaudhury, S. Mehnaz, J.M. Robinson, W.L. Hayton, D.K. Pearl, D.C. Roopenian, C.L. Anderson, The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan, J. Exp. Med. 197 (2003) 315-322.
45. D.B. Tesar, N.E. Tiangco, P.J. Bjorkman, Ligand valency affects transcytosis, recycling, and intracellular trafficking mediated by the neonatal Fc receptor, Traffic 7 (2006) 1127-1142.
46. T.M. Dillon, M.S. Ricci, C. Vezina, G.C. Flynn, Y.D. Liu, D.S. Rehder, M. Plant, B. Henkle, Y. Li, S. Deechongkit, B. Varnum, J. Wypych, A. Balland, P.V. Bondarenko, Structural and functional characterization of disulfide isoforms of the human IgG2 subclass, J. Biol. Chem. 283 (2008) 16206-16215.
47. J. Wypych, M. Li, A. Guo, Z. Zhang, T. Martinez, M.J. Allen, S. Fodor, D.N. Kelner, G.C. Flynn, Y.D. Liu, P.V. Bondarenko, M.S. Ricci, T.M. Dillon, A. Balland, Human IgG2 antibodies display disulfide-mediated structural isoforms, J. Biol. Chem. 283 (2008) 16194-16205.